A pragmatic Roadmap for the pharmaceutical and medtech industries to digitize their conference and events channels. Presentation is a follow-up to an earler deck: 'The Medical Conference is Dead. Long Live the Medical Conference'.
#ChatAfib: Pharma industry's first-ever open tweet chatLen Starnes
Analysis of the pharma industry's first.ever tweet chat: Boehringer Ingelheim's #ChatAfib, staged during the 2013 European Society of Cardiolgy Congress. The first of two presentations exploring the impact of social media and digital technologies on professional medical conferences
My talk during the Digital4 Pharma conference, July 2016 in Greece. My talk described the digital transformation of Takeda with our vision and how Takeda Pharmaceutical explore initiatives and trends in order to provide better services to healthcare professionals. Virtual Reality was one of the experiments which Takeda Hellas implemented in the framework of digital new way of thinking. Key findings are cross-functional collaboration, focus on the objectives and needs of our HCPs. Conclusion: if we benefit from the combination of the technology and traditional marketing aspects then the results will be a good mix of creative and quality actions .
Presentation delivered at the Russian Pharmaceutical Forum, St Petersburg, 17 - 19 June 2014, an update of a presentation first delivered in 2012: 'Making sense of multichannel'. The focus is on the progress of pharma multichannel marketing during the period 2012 to 2014, highlighting frequently cited hurdles, significant common practices, and emerging trends.
This presentation served as the basis of a Twitter reporter training programme developed for the 2014 European Society of Cardiology Congress which took place in Barcelona August 30th to September 3rd.
It asks the question: what is a ‘valuable tweet’ in the context of a medical society conference? It further explores the ontology of tweets that could be regarded as valuable during medical meetings and conferences.
Whilst the issue of the use of Twitter at medical conferences has been intensively discussed during recent years, the focus of the dialogue has primarily been the nature and scale of the disruption on traditional physical conference formats. By contrast, this presentation explores the qualitative nature of tweets that add value to scientific debate.
Comments on this presentation would be most welcome.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Emergent hybrid medical society conferences: evidence of disruption; impact o...Len Starnes
Presentation first given at the 2015 Eyeforpharma Barcelona Conference; an update of a presentation given in 2013 on the emergent hybrid medical society physical/virtual conference format. Evidence of conference format disruption is presented based on the 2014 European Society of Cardiology Congress. The impact on the pharma industry is explored.
Disrupted Medical Conferences: What does it mean for Italian pharmas?Len Starnes
Presentation given during a Merqurio.it webinar 26 March 2021. Outlines the implications of covid-disrupted medical society conferences for the Italian pharma industry and the pharma industry in general: likely conference formats 2021; emerging formats 2022 and beyond; % Italian doctors attending major events; hybrid complexity from a pharma perspective; 4 key pharma survival strategies.
#ChatAfib: Pharma industry's first-ever open tweet chatLen Starnes
Analysis of the pharma industry's first.ever tweet chat: Boehringer Ingelheim's #ChatAfib, staged during the 2013 European Society of Cardiolgy Congress. The first of two presentations exploring the impact of social media and digital technologies on professional medical conferences
My talk during the Digital4 Pharma conference, July 2016 in Greece. My talk described the digital transformation of Takeda with our vision and how Takeda Pharmaceutical explore initiatives and trends in order to provide better services to healthcare professionals. Virtual Reality was one of the experiments which Takeda Hellas implemented in the framework of digital new way of thinking. Key findings are cross-functional collaboration, focus on the objectives and needs of our HCPs. Conclusion: if we benefit from the combination of the technology and traditional marketing aspects then the results will be a good mix of creative and quality actions .
Presentation delivered at the Russian Pharmaceutical Forum, St Petersburg, 17 - 19 June 2014, an update of a presentation first delivered in 2012: 'Making sense of multichannel'. The focus is on the progress of pharma multichannel marketing during the period 2012 to 2014, highlighting frequently cited hurdles, significant common practices, and emerging trends.
This presentation served as the basis of a Twitter reporter training programme developed for the 2014 European Society of Cardiology Congress which took place in Barcelona August 30th to September 3rd.
It asks the question: what is a ‘valuable tweet’ in the context of a medical society conference? It further explores the ontology of tweets that could be regarded as valuable during medical meetings and conferences.
Whilst the issue of the use of Twitter at medical conferences has been intensively discussed during recent years, the focus of the dialogue has primarily been the nature and scale of the disruption on traditional physical conference formats. By contrast, this presentation explores the qualitative nature of tweets that add value to scientific debate.
Comments on this presentation would be most welcome.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Emergent hybrid medical society conferences: evidence of disruption; impact o...Len Starnes
Presentation first given at the 2015 Eyeforpharma Barcelona Conference; an update of a presentation given in 2013 on the emergent hybrid medical society physical/virtual conference format. Evidence of conference format disruption is presented based on the 2014 European Society of Cardiology Congress. The impact on the pharma industry is explored.
Disrupted Medical Conferences: What does it mean for Italian pharmas?Len Starnes
Presentation given during a Merqurio.it webinar 26 March 2021. Outlines the implications of covid-disrupted medical society conferences for the Italian pharma industry and the pharma industry in general: likely conference formats 2021; emerging formats 2022 and beyond; % Italian doctors attending major events; hybrid complexity from a pharma perspective; 4 key pharma survival strategies.
Digital disruption: What should patient organizations do to stay ahead?Len Starnes
Extended version of a presentation given at Roche's International Experience Exchange for Patient Organizations conference, Athens, 14 - 15 March, 2018. #IEEPO2018
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
Going social: why patient organizations cannot ignore social media Len Starnes
Presentation goven at the 7th Annual International Experience Exchange for Patient Organizations, Munich, 3 - 4 March 2015; #IEEPO2015. The event was sponsored by Roche.
Some 300 participants attended representing over 40 patient organizations worldwide. The final day of the meeting was dedicated to social media and how they can help patient organizations achieve their goals
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Multichannel Pharma Marketing by Wiley InterfaceWiley Asia
Are you maximizing your reach to physicians?
Today’s physicians get medical information via multiple channels – conferences, peer-reviewed journals, your communications both online and offline. Find out how you can determine the right channel mix for your physicians to communicate your brand’s message effectively.
Watch our video to learn more and apply multichannel marketing in practice to boost 10% growth.
mHealth and Digital Masters : Novartis Vs KodakJoseph Pategou
During years, pharma companies have been trying to bring more value to patients and physicians by using mHealth.
In this study we observed the consequences of a slow transition to digital on a leader in his sector (Novartis Vs Kodak). We also think that pharma companies need to move from mHealth to Digital Masters to bring the best value to all stakeholders.
Some facts:
Digital Masters outperform their peers*
-26% more profitable than their average industry competitors
-9% percent more revenue with their existing physical capacity
-More efficiency in their existing products and processes
-More Productivity
(*): LEADING DIGITAL: Turning technology into business transformation, Havard Business Review press
Engaging hcp and patients through a Multichannel campaign - eyeforpharma Ista...Sven Awege
Pharma context
Dozens of channels (for HCP & the rest of us)
Channel coverage - today and tomorrow
…and then there’s the sticky question on messages & channels?
…not forgetting compliance & privacy..
…Medical & Regulatory…
..human resistance to change…
…and infrastructure capabilities!
And then there’s that wierd thing happening in social media and mobile devices
Summary:
The concept of closed-loop real-time multi-channel marketing is great, but…
Start with baby steps to learn how to run
Use common sense, ROI calculations are probably impossible to prove and will distract us from focusing on what matters
Absolute clarity on objectives and how to measure results
Key Learnings:
Estimate time necessary then triple it
Validate your objectives (MR, focus groups)
Focus on fewer channels but execute with excellence
Channel selection:
Suitability for objective, Reach, impact, CPI
Internal marketing & educating
Establish processes, R&R
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
Presentation at the 2017 joint annual convention of the Philippine Society of Hypertension & Philippine Lipid & Atherosclerosis Society 25 Feb 2017, Crowne Plaza Galleria Manila.
Digital disruption: What should patient organizations do to stay ahead?Len Starnes
Extended version of a presentation given at Roche's International Experience Exchange for Patient Organizations conference, Athens, 14 - 15 March, 2018. #IEEPO2018
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
Going social: why patient organizations cannot ignore social media Len Starnes
Presentation goven at the 7th Annual International Experience Exchange for Patient Organizations, Munich, 3 - 4 March 2015; #IEEPO2015. The event was sponsored by Roche.
Some 300 participants attended representing over 40 patient organizations worldwide. The final day of the meeting was dedicated to social media and how they can help patient organizations achieve their goals
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Multichannel Pharma Marketing by Wiley InterfaceWiley Asia
Are you maximizing your reach to physicians?
Today’s physicians get medical information via multiple channels – conferences, peer-reviewed journals, your communications both online and offline. Find out how you can determine the right channel mix for your physicians to communicate your brand’s message effectively.
Watch our video to learn more and apply multichannel marketing in practice to boost 10% growth.
mHealth and Digital Masters : Novartis Vs KodakJoseph Pategou
During years, pharma companies have been trying to bring more value to patients and physicians by using mHealth.
In this study we observed the consequences of a slow transition to digital on a leader in his sector (Novartis Vs Kodak). We also think that pharma companies need to move from mHealth to Digital Masters to bring the best value to all stakeholders.
Some facts:
Digital Masters outperform their peers*
-26% more profitable than their average industry competitors
-9% percent more revenue with their existing physical capacity
-More efficiency in their existing products and processes
-More Productivity
(*): LEADING DIGITAL: Turning technology into business transformation, Havard Business Review press
Engaging hcp and patients through a Multichannel campaign - eyeforpharma Ista...Sven Awege
Pharma context
Dozens of channels (for HCP & the rest of us)
Channel coverage - today and tomorrow
…and then there’s the sticky question on messages & channels?
…not forgetting compliance & privacy..
…Medical & Regulatory…
..human resistance to change…
…and infrastructure capabilities!
And then there’s that wierd thing happening in social media and mobile devices
Summary:
The concept of closed-loop real-time multi-channel marketing is great, but…
Start with baby steps to learn how to run
Use common sense, ROI calculations are probably impossible to prove and will distract us from focusing on what matters
Absolute clarity on objectives and how to measure results
Key Learnings:
Estimate time necessary then triple it
Validate your objectives (MR, focus groups)
Focus on fewer channels but execute with excellence
Channel selection:
Suitability for objective, Reach, impact, CPI
Internal marketing & educating
Establish processes, R&R
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
Presentation at the 2017 joint annual convention of the Philippine Society of Hypertension & Philippine Lipid & Atherosclerosis Society 25 Feb 2017, Crowne Plaza Galleria Manila.
How Anesthesiologists Can Use Social MediaBrianne Aiken
As the Department of Anesthesiology's digital communications manager, I spend a lot of time integrating social media into our promotion and outreach strategy.
Position 0 seocampus 2017 (Featured Snippets)DOUCET Raphael
Voici les slides de ma conférence sur les Featured Snippets (position 0) au SEO CAMPUS Paris 2017. Ne manquez pas d'ici quelques jours un billet complet sur le sujet avec encore plus d'infos et de chiffres pour les featured Snippets en France sur http://www.visibilite-referencement.fr/blog/
Physicians' Social Networks: A New Tool in Global Health Len Starnes
Presentation first given at the Digital Health Summit Turkey, Istanbul, December 17 2015. Focus of the presentation is the emerging role of physicians' social networks in supporting national health reform programmes and managing pandemic threats.
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
The most thrilling international pharma events, from conferences to meetings & workshops, this is the list not to be missed for pharma professionals.
Check out our list of Top 10 Pharmaceutical conferences:
1. International Conference on Cell and Gene Therapy
2. BIO-Europe Spring 2021
3. DUPHAT- 2021 : https://duphat.ae/
4. CPHI India 2021
5. DIA Europe 2021
6. BIO Asia International Conference 2021
7. BIO International Convention
8. CAR TCR EUROPE 2021
9. Pharma Forum 2021
10. 4th Annual Bioprocessing Summit Europe
NOAH Berlin 2018 Startups Winners: Company Presentation by Julia Hoxha, Zana at the NOAH Conference 2018 in London, Old Billingsgate 30-31 October 2018.
Digital Health & Wellness: Panel with David Meinertz, CEO (Zava) - Johannes Schildt, Co-Founder & CEO (KRY) - Ali Parsa, Founder & CEO (Babylon Health) - Rainer Kasan, Co-Founder & CTO (Telepaxx) - Dan Vahdat, Founder & CEO (Medopad) at the NOAH Conference 2018 in London, Old Billingsgate 30-31 October 2018.
The Medical Learning Hub (MLH) is an e-learning platform that enables healthcare professionals (HCPs) to train and interact with leading medical experts globally. It provides professionals with current medical knowledge and the opportunity to engage with peers and colleagues from across the globe in live webinars, on-demand online courses as well as on-site training opportunities.
https://medicallearninghub.com/
The new normal is already here. A 'new' new normal loomsLen Starnes
This presentation is an update to a 2-part review of disrupted medical conferences published on Pharmaphorum March 15th and 16th 2022 .
It reflects recent trends and current disruptive global warnings, events, and threats likely to further impact medical meetings
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
The Medical Learning Hub (MLH) is an e-learning platform that enables healthcare professionals (HCPs) to train and interact with leading medical experts globally and our ambition is to transform medical training by democratizing and making available the latest innovations and opportunities to all HCPs in a highly efficient way.
Disrupted medical conferences: THE BIG PICTURELen Starnes
An in-depth analysis of the impact of covid on medical conferences: lessons learnt 2020-2021; consequences for all major stakeholders 2022; scenarios for 2022 and beyond. A visual abstract presents the full analysis.
The future of scientific congresses: what can we learn from the medical world?Len Starnes
Keynote presentation given during the November 26 Digital University Day organized by the Delft University of Technology, The Netherlands. Focuses on the transformation of medical society congresses to virtual formats during 2020, highlighting outcomes relevant for academic science and technology events.
شبكات تواصل اجتماعي للأطبّاءتعزيز معايير الرعاية الطبّيّة دعم برامج الرعاية...Len Starnes
عرض تقديمي يقدّم للأطبّاء من منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي يوضّح مكانة شبكات الأطبّاء الاجتماعيّة في العالم وتأثيرها على ممارسة مهنة الطبّ. تركيز خاصّ على إمكانيّات الشبكات الكامنة في منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي، مع التركيز على الفرص التي تقدّمها لدعم برامج الإصلاحات الوطنيّة في مجال الرعاية الطبيّة. دروس ومقارنات من الصين.
Doctors' Social Networks: Boosting standards of medical care. Supporting heal...Len Starnes
Presentation given to doctors from the MENA/GCC region outlining the scale of doctors’ social networks worldwide and their impact on the practice of medicine. Special focus on the potential of networks in the MENA/GCC region, highlighting opportunities they offer to support national healthcare reform programmes. Lessons and parallels from China.
Will global HCPs networks become communities of choice for rare-disease speci...Len Starnes
Analysis of the role of global HCPs' social networks in the management of rare diseases. Case study of the G-Med global neuroendocrine tumour specialist community
The Rise and Rise of HCPs' Social Networks - Focus on GCC RegionLen Starnes
Presentation given at the 5th Saudi eHealth Conference, Riyadh, 18 – 20 November 2014. The agenda includes: an update on the status of the continuing global expansion of HCPs’ social networks; a look at networks in the Gulf Cooperation Council (GCC) region; an overview of differentiating network characteristics; physicians’ usage patterns; impacts on national healthcare systems; and a case for the creation of a dedicated Saudi Arabian network to support the objectives of the country’s new healthcare reform.
Introductory presentation to an EphMRA Masterclass workshop follow-up webinar given 6 December 2012. The original Masterclass workshop was delivered in Paris June 2012 at the EphMRA '360 Future' conference.
This translation was made possible with the kind and generous help of Jahee Lee, Dreamwiz, Korea. www.dreamwiz.com
In Korean: Making Sense of Multichannel (in the pharma industry)Len Starnes
Presentation first given at the Digital Health Summit Turkey, Istanbul, 11 – 12 September 2012. This was the first event of its type in Turkey with representatives of all major healthcare stakeholders: HCPs, patients, pharma, payers, government, academia, regulators, digital agencies and the media. Some 200 delegates participated.
http://www.ptms.com.tr/
This translation was made possible by the kind and generous help of Jahee Lee, Dreamwiz, Korea. www.dreamwiz.com
In Russian: The Digital Metamorphosis of the Pharma Industry Len Starnes
Russian translation of a presentation first given at the Pharma Digital Marketing Summit, Istanbul, February 2012. This translation was made possible by the kind and generous help of Oxana Kolosova, Managing Partner of iVrach: www.ivrach.com.
In Russian: Making Sense of Multichannel (in the pharma industry)Len Starnes
Presentation first given at the PTMS Digital Health Summit, Istanbul, 11 - 12 September 2012. The core theme is the difficulty the pharma industry faces in understanding and implementing effective multichannel marketing programmes. This translation was made possible with the kind and generous assistance of Oxana Kolosova, Managing Partner of iVrach: www.ivrach.com.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
7. Is it worth it?
€216,000
inc VAT
http://www.escexhibition.org/ESCCongress2016/Documents/ESCIP2016_LR.pdf
8. Industry stand space
at ESC Congress 2015:
8,380 m2
http://escardio.formstack.com/forms/esc_2016__exhibition_space_application_form
Cost of 8,380 m2 at
ESC Congress 2016:
€ 4,235,520
Stand construction costs and service charges not included
http://www.escexhibition.org/ESCCongress2016/default.aspx
9. Opt for physical
conference attendance
selectively, increasingly
disinclined to travel
Increasingly turn to live
& recorded online video
for medical education
Perceive conferences
as 365 interactive
conversations
Digital
doctors
10. Videos viewed by
HCPs last 12 months
Among those watching professional videos online
Manhattan Research, Taking the Pulse USA 2015
56%CME
Medical news
Mode of action
Patient information
Other
Medical procedure
demos
Disease/condition
info
Lectures/seminars
Drug efficacy
56%
46%
36%
34%
31%
17%
16%
16%
3%
HCPs view online video as a
crucial educational tool
12. Column1
Impact of codes
already significant
53% report codes
restricting physical
attendance
Among 237 specialists in
USA, UK, France, Germany,
Italy, Spain, Russia, Turkey,
China, Brazil, and Argentina
who had attended a medical
conference in 2015
https://www.ashfieldhealthcare.com/gb/the-formula-to-successful-meetings/
13. Eliminated payments
to HCPs speaking at
company-sponsored
symposia
Eliminated payments of
travel expenses to HCPs
attending conferences
Hans Gilhuys
GlaxoSmithKlineUK
Exl Digital Pharma Europe 2016
14. Technology drives
adoption of new
engagement
models
Traditional channels
often fail to meet
HCPs preferred types
of engagement
‘
15. Column1
Significant dissatisfaction
with physical meetings
39% report
negative experience
Among 237 specialists in
USA, UK, France, Germany,
Italy, Spain, Russia, Turkey,
China, Brazil, and Argentina
who had attended a medical
conference in 2015
https://www.ashfieldhealthcare.com/gb/the-formula-to-successful-meetings/
16. Sophisticated platforms meet
demands of doctors & pharmas
Live +
on demand
video
Real-time
Q&A & polling
Global
access
Connect
from any
device
Actionable
engagement metrics
23. Basics
Create an analogous interactive
environment to a traditional conference
Use CME & EACCME accreditation
to incentivize participation
Leverage an existing therapeutically-
focused platform to increase reach
24. Learn best practices
Partner with specialist healthcare
platform vendors and leading
medical education institutions
26. Partnership with American
Heart Rhythm Society
Firewalled Tikosyn
speaker session & booth
CME credits from
Johns Hopkins
Hosted on
CardioCareLive 6 months
31. As conservative as pharma
Often content with conference
formats unchanged for over
100 years
Deeply sceptical of new
conference formats that
disrupt revenue streams
Yet to understand the
opportunities virtual-physical
conference collaboration with
pharma afford
Medical
societies
32. Multiple options…
expect more soon
Sponsored sessions
& events hosted on
medical society platform
Independent virtual
conference highlights
package
Independent virtual
conference extending
the physical experience
33. 50th ASCO Annual Meeting
Highlights
Sponsored by a
pharma, medtech
& cancer charity
Hosted on MD Linx
medical portal &
Doctors.net.uk
HCPs social network‘
34. Educate 5 specialities on latest
treatments presented at ASCO
Annual Meeting 2014
The brief
Target specialities in 16
European countries using
4 languages
Reach target specialities using
effective alternative channel to
attending in person
35. Key results
Engagement before, during, post ASCO
72,393 newsletter alert emails opened
6,673 visits to Highlights microsite
€ 13 average cost per microsite visit
Courtesy: M3 Europe, UK
37. 3 x 60 min CME sessions
broadcast live from
Frankfurt, April 2014
Speakers from
Australia, Spain, USA
CME/EACCME credits from
Einstein College of Med
Hosted on
CardioCareLive 6 months
38. Key results
751 live participants
1249 on-demand participants
Participants from 32 countries
Almost 49 min engagement/session
83% of participants reported
positive learnings
Courtesy: PlatformQ, USA
39. Medical society platforms
offer trust, deliver reach
http://www.escexhibition.org/ESCCongress2016/Documents/ESCIP2016_LR.pdf
ESC Congress
2016
40. Use of medical society
platforms just beginning
Many restrict hosting to
sponsored accredited CME
Opportunities to co-
develop fully-compliant
win-win collaboration
strategies
Collaborating
with medical
societies
46. A sincere thanks to the following for
their help and support in developing
this presentation
• Hans Gilhuys, Multichannel Director Europe,
GlaxoSmithKlein UK
• David Murphy, Executive Vice President,
PlatformQ
• Tim Ringrose, CEO, M3 Europe
• Robert Rosenbloom, President & CEO,
PlatformQ
47. lenstarnes@gmail.com
T: + 49 30 781 5513
M: + 49 172 1788253
Skype: lenstarnes
linkedin.com/in/lenstarnes
twitter.com/lenstarnes
slideshare.net/lenstarnes
Len Starnes
Digital Healthcare
Research & Consulting